In 'First-of-Its-Kind' Criminal Case, SDNY Announces $20 Million Fine Against Opioid Distributor
The Rochester drug distributor's oxycodone order fulfillment increased eightfold over a four-year period, despite numerous internal warnings that the sales were driven by suspect behavior.
April 23, 2019 at 03:45 PM
5 minute read
The original version of this story was published on New York Law Journal
Federal authorities in Manhattan announced criminal charges Tuesday against the Rochester Drug Co-Operative and two of its former executives for unlawfully distributing opioids in what U.S. Attorney Geoffrey Berman of the Southern District of New York called a first-of-its-kind prosecution.
“Our Office will do everything in its power to combat this epidemic, from street-level dealers to the executives who illegally distribute drugs from their boardrooms,” he said in a statement.
The western New York wholesale pharmaceutical distributor is one of the nation's largest of its kind, with more than 1,300 pharmacy customers and $1 billion in revenue, according to prosecutors. They claim that the company distributed oxycodone, fentanyl, and other drugs to customers its own internal compliance personnel determined were dealing the drugs to others, prosecutors claimed. The decision to do so came from senior management, including the company's former CEO, Laurence Doud III, and COO, William Pietruszewski.
Prosecutors said the company and its leadership knowingly ignored red flags that continued to pop up. Order for unusually high quantities of the addictive drugs, a high percentage of cash being used to pay for prescriptions, and the filling of scripts by doctors who would not normally be prescribing painkillers were just a few of the signs federal authorities claim Rochester Drug Co-Operative leadership willfully ignored.
Despite the raised suspicions, and even concerns some of the pharmacies were “DEA investigations in the making,” employees' concerns went unheeded, while profits at the company soared.
According to federal authorities, Doud allegedly directed the increase of sales of oxycodone from 4.7 million to 42.2 million, or an increase of about 800%, between 2012 and 2016. During the same time period fentanyl sales grew from 63,000 dosages to more than 1.3 million, an increase of approximately 2,000%. Doud, for his part, was compensated accordingly: prosecutors claim he made over $1.5 million in 2016, an increase of 125% over the same time period.
Prosecutors said that in addition to turning a blind eye to where its drugs were going, the company also sought to conceal its actions from law enforcement. Doud, according to prosecutors, directed Pietruszewski not to report suspect pharmacies to the Drug Enforcement Agency. The company went so far as to open new accounts without conducting due diligence, including some that lost prior distributors over concerns, despite telling the DEA it was in compliance, authorities said.
This pattern of behavior played out in the numbers. Between 2012 and 2016, 8,300 potentially suspicious orders were flagged internally by Rochester Drug Co-Operative. Yet only four suspicious orders ever made their way to the DEA.
“Today's charges should send shock waves throughout the pharmaceutical industry reminding them of their role as gatekeepers of prescription medication,” DEA Special Agent in Charge Ray Donovan said in a statement. “The distribution of life-saving medication is paramount to public health; similarly, so is identifying rogue members of the pharmaceutical and medical fields whose diversion contributes to the record-breaking drug overdoses in America.”
At the same time the charges were announced, federal prosecutors unveiled a deferred prosecution agreement with the drug company, and a cooperation deal with Pietruszewski.
Rochester Drug Co-Operative will pay a $20 million fine, and be subject to a three-year compliance monitoring that will include regular progress reports to the DEA.
Company spokesman Jeff Eller said in a statement that the drug company accepts responsibility for its mistakes.
“We made mistakes and RDC understands that these mistakes, directed by former management, have serious consequences,” Eller's said. “We can do better, we are doing better, and we will do better.”
According to federal prosecutors, Pietruszewski pleaded guilty to multiple conspiracy charges related to distribution of a controlled substance, fraud, and failing to report. He is represented by Porzio, Bromberg & Newman principal William Hughes Jr., who told the New York Law Journal Pietruszewski accepted responsibility and is looking forward to moving on with his life.
Doud was charged with conspiracy to distribute and to defraud the U.S. Gottlieb & Janey name partner Robert Gottlieb represents him in the matter.
In a statement, Gottlieb said his client was being “framed, plain and simple.”
“The Government has it all wrong and is being used by others to cover up their wrongdoing,” Gottlieb said. “Mr. Doud will fight these false charges to his last breath and he will be vindicated.”
The company was represented in the matter by Hyman, Phelps & McNamara director Douglas Farquhar.
Related:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllSoundCloud GC Takes Legal Reins of Condé Nast at Tumultuous Time
Senate Panel Postpones Vote on Reconfirmation of Democrat Crenshaw to SEC
As AI-Generated Fraud Rises, Financial Companies Face a Long Cybersecurity Battle
Trending Stories
- 1City Bar Presents Thomas E. Dewey Awards to Outstanding NYC Prosecutors
- 2NC Solicitor General Park Withdraws His 4th Circuit Nomination
- 3Trump-Appointed Judge Presides Over NASCAR Antitrust Dispute Under Case Reassignment
- 4CFPB Orders Big Banks to Limit Overdraft Fees to $5. But Will Its Edict Stick?
- 5FIFA Faces Legal Challenge Over Winning Saudi World Cup Bid
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250